Society of Immunotherapy for Cancer (SITC)

#Antigen #Cancer vaccine #Drug development #Drug discovery #Infinitopes #Society of Immunotherapy for Cancer (SITC)

Breakthroughs on cancer vaccine development at SITC 2024 

Infinitopes presented three posters on its cancer vaccine discovery and development strategy, including one that has been recognised as a ‘top 100’ poster presentation, at the Society for Immunotherapy of Cancer (SITC) 2024, held in Houston, US, from 6-10 November.  A spinout from Oxford University, supported by Cancer Research UK (CRUK),… Read More

#Cancer Research #News

Cancer tumour
#Cancer therapeutics #Clinical trials #Immunology #Society of Immunotherapy for Cancer (SITC) #Storm Therapeutics

New clinical data on first-in-class METTL3 inhibitor 

Storm Therapeutics has presented promising data from its Phase I clinical study evaluating its METTL3 RNA methyltransferase inhibitor, STC-15, at the Society of Immunotherapy for Cancer (SITC) 39)th Annual Meeting, held in Houston, US, from 6-10 November 2024.    The Phase I clinical study… Read More

#News